Literature DB >> 10449067

What can predict postoperative "endocrinological cure" in Cushing's disease?

S Nishizawa1, Y Oki, S Ohta, N Yokota, T Yokoyama, K Uemura.   

Abstract

OBJECTIVE: The goal of surgical treatment for Cushing's disease is "endocrinological cure." The purpose of this study was to determine predictors for postoperative endocrinological cure in Cushing's disease.
METHODS: Postoperative endocrinological studies were evaluated in 18 patients with Cushing's disease who underwent transsphenoidal surgery for selective adenomectomy. Serum adrenocorticotropic hormone (ACTH) levels were measured by radioimmunoassay during the first week after surgery. One week after surgery, a test using corticotropin-releasing hormone (CRH) was performed on each patient to check the reserve function of normal ACTH-secreting cells.
RESULTS: In eight patients, postoperative ACTH levels were below the measurable level for 1 week, and ACTH showed no response to the CRH test. In these patients, serum ACTH and cortisol levels were kept in the normal range with a normal diurnal variation during long-term follow-up. These patients can be defined as endocrinologically cured. In seven patients, the ACTH level returned to within normal range on the day after surgery, but ACTH was provoked by the CRH test. Five of these seven patients showed subsequent re-elevation of ACTH above the normal range. ACTH levels were never normalized in the remaining three patients, and medical treatments were unavoidable.
CONCLUSION: The most reliable indicators for predicting endocrinological cure in Cushing's disease are no response of ACTH to the CRH test in the early postoperative stage and an unmeasurably low ACTH level in the week after surgery. Obtaining a normal range of ACTH level postoperatively is insufficient to define endocrinological cure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449067     DOI: 10.1097/00006123-199908000-00007

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  The dynamics of post-operative plasma ACTH values following transsphenoidal surgery for Cushing's disease.

Authors:  Lakshmi Srinivasan; Edward R Laws; Robert L Dodd; Monique M Monita; Christyn E Tannenbaum; Kjersti M Kirkeby; Olivia S Chu; Griffith R Harsh; Laurence Katznelson
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

Review 2.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

3.  The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery.

Authors:  John R Lindsay; Edward H Oldfield; Constantine A Stratakis; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2011-04-20       Impact factor: 5.958

4.  Significance of absent prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I--immunohistochemical study.

Authors:  S Ohta; S Nishizawa; Y Oki; T Yokoyama; H Namba
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

5.  Long-term remission and recurrence rate in a cohort of Cushing's disease: the need for long-term follow-up.

Authors:  G Aranda; J Enseñat; M Mora; M Puig-Domingo; M J Martínez de Osaba; G Casals; E Verger; M T Ribalta; F A Hanzu; I Halperin
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

6.  Comparisons between macroadenomas and microadenomas in Cushing's disease: characteristics of hormone secretion and clinical outcomes.

Authors:  You-Cheol Hwang; Jae Hoon Chung; Yong-Ki Min; Myung-Shik Lee; Moon-Kyu Lee; Kwang-Won Kim
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.